NOT-FD-12-011: Notice of Correction to Application Due Date, Expiration Date, Funds Available, Award Budget and Award Project Period for RFA-FD-12-019 Predictive Lung Deposition Models for Safety and Efficacy of Orally Inhaled Drug Products (U01)

Notice of Correction to Application Due Date, Expiration Date, Funds Available, Award Budget and Award Project Period for RFA-FD-12-019 Predictive Lung Deposition Models for Safety and Efficacy of Orally Inhaled Drug Products (U01)

Notice Number: NOT-FD-12-011

Key Dates

Release Date: May 25, 2012

Related Notices

RFA-FD-12-019

Issued by

U.S. Food and Drug Administration (FDA)

Purpose

The purpose of this Notice is to correct the Application Due Date, Expiration Date, Funds Available, Award Budget and Award Project Period for RFA-FD-12-019.

Now Reads:

Application Due Dates

May 31, 2012, by 5:00 PM local time of applicant organization.

Should Read:

Application Due Dates

June 8, 2012, by 5:00 PM local time of applicant organization.

Now Reads:

Expiration Date

June 1, 2012

Should Read:

Expiration Date

June 9, 2012

Now Reads:

Funds Available and Anticipated Number of Awards

The number of awards is contingent upon FDA appropriations and the submission of a sufficient number of meritorious applications received. FDA/CDER intends to commit up to $300,000 in FY 2012.

It is anticipated that one (1) award will be made, not to exceed $300,000 in total costs (direct plus indirect).

Award Budget

The amount of financial assistance requested from FDA may not exceed $300,000.

Award Project Period

1 year

Should Read:

Funds Available and Anticipated Number of Awards

The number of awards is contingent upon FDA appropriations and the submission of a sufficient number of meritorious applications received. FDA/CDER intends to commit up to $150,000 in FY 2012.

It is anticipated that one (1) award will be made.

Award Budget

The amount of financial assistance requested from FDA may not exceed the following:

Year 01: $150,000

Year 02: $150,000

Award Project Period

The total project period will be 2 years. An additional year of support will be available depending upon fiscal year appropriations and successful performance. The total project period for an application requesting support may not exceed 2 years.

All other aspects of the FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Lisa Ko
Grants Management Specialist
U.S. Food and Drug Administration
Office of Acquisition and Grants Services
5630 Fishers Lane Room 1096
Rockville, MD 20857
TEL: 301-827-5095
FAX: 301-827-1044
EMAIL: Lisa.Ko@fda.hhs.gov